Throughout Election Day and night, CBS News' Confirmed team will be fact checking reports of threats around voting today, voter fraud, election hacking, and more as the nation votes and waits to ...

Earlier this month, Edwards published a fact sheet that said, among other things, “FEMA has NOT diverted disaster response funding to the border or foreign aid.” Third, it’s not true that FE ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

In a world of wild talk and fake news, help us stand up for the facts.

Trump said his new WH chief of staff likes to ‘stay in the back.’ Randi Kaye explains why he is right What Kaitlan Collins is hearing from inside Mar-a-Lago about the fight for jobs in Trump ...

Distrust in science and facts has always been around. Whether it was the debate about evolution or the age of the Earth, when science and belief are in conflict, people tend to lean into discrediting ...

A fact-check in the ABC News presidential debate has aged poorly after the FBI quietly made a stunning correction about violent crime rates in the U.S. In last month's political showdown between ...

Full fact check: Sign with swastika 'absolutely not' from Trump campaign, GOP official says There is no evidence Rogan made such a statement against Trump. This was further confirmed late on Nov ...

An Oct. 21 Threads post (direct link, archive link) claims to share news of a change one state purportedly made before the election. “BREAKING: Florida Governor Ron DeSantis says Dominion voting ...

But does anyone even care anymore? In an interview with POLITICO Magazine, Adair made the case that yes, fact-checking does still matter and can make a difference, even in an age of disinformation ...

Conservatives and social media commentators began sharing claims on election night that Google had been projecting a pro-Kamala Harris bias, alleging results mapped where voters could cast their ...

Mirvetuximab soravtansine demonstrated efficacy in heavily pretreated patients with FRα+, platinum-sensitive ovarian cancer, achieving a 51.9% objective response rate in the PICCOLO trial.